Jiangsu Nanfang Medical (603880) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.048x

Based on the latest financial reports, Jiangsu Nanfang Medical (603880) has a cash flow conversion efficiency ratio of 0.048x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥12.53 Million ≈ $1.83 Million USD) by net assets (CN¥259.57 Million ≈ $37.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Jiangsu Nanfang Medical fund operations to measure how many days the company can operate on defensive assets alone.

Jiangsu Nanfang Medical - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Jiangsu Nanfang Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jiangsu Nanfang Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Nanfang Medical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Strattec Security Corporation NASDAQ:STRT	0.043x
PCB Bancorp NASDAQ:PCB	0.042x
Green Cross KO:005250	0.074x
CHECKPOINT THER. DL-0001 F:CZTA	N/A
Ausgold Ltd AU:AUC	-0.012x
LINKBANCORP Inc NASDAQ:LNKB	-0.023x
Founders Metals Inc. V:FDR	-0.013x
Citizens Financial Services Inc. Common Stock NASDAQ:CZFS	0.052x

Annual Cash Flow Conversion Efficiency for Jiangsu Nanfang Medical (2012–2025)

The table below shows the annual cash flow conversion efficiency of Jiangsu Nanfang Medical from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Jiangsu Nanfang Medical market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥181.17 Million ≈ $26.51 Million	CN¥47.73 Million ≈ $6.98 Million	0.263x	+18.34%
2024-12-31	CN¥284.41 Million ≈ $41.62 Million	CN¥63.32 Million ≈ $9.27 Million	0.223x	+580.74%
2023-12-31	CN¥474.22 Million ≈ $69.39 Million	CN¥15.51 Million ≈ $2.27 Million	0.033x	-35.01%
2022-12-31	CN¥621.48 Million ≈ $90.94 Million	CN¥31.28 Million ≈ $4.58 Million	0.050x	+139.12%
2021-12-31	CN¥654.90 Million ≈ $95.83 Million	CN¥-84.25 Million ≈ $-12.33 Million	-0.129x	-158.50%
2020-12-31	CN¥700.80 Million ≈ $102.55 Million	CN¥154.12 Million ≈ $22.55 Million	0.220x	+278.28%
2019-12-31	CN¥567.52 Million ≈ $83.05 Million	CN¥32.99 Million ≈ $4.83 Million	0.058x	-38.28%
2018-12-31	CN¥560.04 Million ≈ $81.95 Million	CN¥52.75 Million ≈ $7.72 Million	0.094x	+2.84%
2017-12-31	CN¥537.57 Million ≈ $78.66 Million	CN¥49.24 Million ≈ $7.20 Million	0.092x	-76.34%
2016-12-31	CN¥256.69 Million ≈ $37.56 Million	CN¥99.35 Million ≈ $14.54 Million	0.387x	-5.01%
2015-12-31	CN¥222.51 Million ≈ $32.56 Million	CN¥90.66 Million ≈ $13.27 Million	0.407x	+16.89%
2014-12-31	CN¥210.90 Million ≈ $30.86 Million	CN¥73.52 Million ≈ $10.76 Million	0.349x	+191.73%
2013-12-31	CN¥168.57 Million ≈ $24.67 Million	CN¥20.14 Million ≈ $2.95 Million	0.119x	-80.93%
2012-12-31	CN¥121.38 Million ≈ $17.76 Million	CN¥76.07 Million ≈ $11.13 Million	0.627x	--

About Jiangsu Nanfang Medical

SHG:603880 China Medical Instruments & Supplies

Market Cap

$325.68 Million

CN¥2.23 Billion CNY

Market Cap Rank

#14518 Global

#4333 in China

Share Price

CN¥7.70

Change (1 day)

-4.47%

52-Week Range

CN¥5.88 - CN¥8.76

All Time High

CN¥16.80